Tyrosine Kinase/Adaptateurs
Les inhibiteurs des tyrosines kinases et des adaptateurs sont des composés qui ciblent les tyrosines kinases et leurs protéines adaptatrices associées, jouant des rôles essentiels dans la signalisation cellulaire, la croissance et la différenciation. Ces inhibiteurs sont des outils essentiels dans la recherche sur le cancer, car de nombreuses tyrosines kinases sont impliquées dans les voies de signalisation qui favorisent la croissance tumorale et les métastases. En inhibant les tyrosines kinases, ces composés peuvent bloquer des cascades de signalisation cruciales, offrant ainsi des stratégies thérapeutiques potentielles pour divers cancers et autres maladies impliquant une signalisation cellulaire anormale. Chez CymitQuimica, nous offrons une gamme complète d'inhibiteurs de tyrosines kinases et d'adaptateurs de haute qualité pour soutenir vos recherches en oncologie, biologie moléculaire et développement de thérapies ciblées.
Sous-catégories appartenant à la catégorie "Tyrosine Kinase/Adaptateurs"
- ALK(112 produits)
- CSF-1R(42 produits)
- EGFR(572 produits)
- Récepteur Ephrin(23 produits)
- FLT(92 produits)
- Récepteur du facteur de croissance des fibroblastes (FGFR)(170 produits)
- SON(5 produits)
- Hck(3 produits)
- IGF-1R(86 produits)
- PDGFR(126 produits)
- PYK2(7 produits)
- Src(78 produits)
- Récepteur TAM(32 produits)
- Tie-2(20 produits)
- Récepteur Trk(59 produits)
- Tyrosine Kinases(27 produits)
- VEGFR(268 produits)
- c-Fms(108 produits)
- c-Kit(101 produits)
- c-Met/HGFR(128 produits)
- c-RET(51 produits)
Affichez 13 plus de sous-catégories
1375 produits trouvés pour "Tyrosine Kinase/Adaptateurs"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Gefitinib
CAS :Formule :C22H24ClFN4O3Degré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :446.91Butein
CAS :Formule :C15H12O5Degré de pureté :>98.0%(HPLC)Couleur et forme :Light yellow to Brown powder to crystalMasse moléculaire :272.26Dasatinib
CAS :Formule :C22H26ClN7O2SDegré de pureté :>95.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :488.01SKLB1002
CAS :Formule :C13H12N4O2S2Degré de pureté :>98.0%(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :320.39NVP-BHG 712
CAS :Formule :C26H20F3N7ODegré de pureté :>95.0%(HPLC)Couleur et forme :White to Light yellow to Light orange powder to crystalMasse moléculaire :503.49Methyl 2,5-Dihydroxycinnamate
CAS :Formule :C10H10O4Degré de pureté :>96.0%(HPLC)Couleur et forme :White to Yellow powder to crystalMasse moléculaire :194.19Tyrphostin AG 835
CAS :Formule :C18H16N2O3Degré de pureté :>98.0%(HPLC)Couleur et forme :Light yellow to Amber to Dark green powder to crystalMasse moléculaire :308.34Afatinib
CAS :Formule :C24H25ClFN5O3Degré de pureté :>97.0%(HPLC)(N)Couleur et forme :White to Orange to Green powder to crystalMasse moléculaire :485.94Curcumin (Natural)
CAS :Formule :C21H20O6Couleur et forme :Light yellow to Brown powder to crystalMasse moléculaire :368.39Tyrphostin A1
CAS :Formule :C11H8N2ODegré de pureté :>98.0%(GC)Couleur et forme :Light orange to Yellow to Green powder to crystalMasse moléculaire :184.20Tyrphostin AG 494
CAS :Formule :C16H12N2O3Degré de pureté :>98.0%(HPLC)(N)Couleur et forme :Light yellow to Amber to Dark green powder to crystalMasse moléculaire :280.28Piceatannol
CAS :Formule :C14H12O4Degré de pureté :>98.0%(HPLC)Couleur et forme :White to Light yellow to Light red powder to crystalMasse moléculaire :244.25SB 431542
CAS :Formule :C22H16N4O3Degré de pureté :>97.0%(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :384.40RPI 1
CAS :Formule :C17H15NO4Degré de pureté :>95.0%(HPLC)Couleur et forme :Light yellow to Brown powder to crystalMasse moléculaire :297.31Axitinib
CAS :Formule :C22H18N4OSDegré de pureté :>95.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :386.47Erlotinib Hydrochloride
CAS :Formule :C22H23N3O4·HClDegré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :429.90Lapatinib
CAS :Formule :C29H26ClFN4O4SDegré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :581.06Imatinib
CAS :Formule :C29H31N7ODegré de pureté :>98.0%(HPLC)Couleur et forme :White to Light yellow to Light orange powder to crystalMasse moléculaire :493.62Tyrphostin A23
CAS :Formule :C10H6N2O2Degré de pureté :>98.0%(GC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :186.17Genistein
CAS :Formule :C15H10O5Degré de pureté :>98.0%(HPLC)Couleur et forme :White to Light yellow to Light orange powder to crystalMasse moléculaire :270.24Sorafenib Tosylate
CAS :Formule :C21H16ClF3N4O3·C7H8O3SDegré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :637.03Curcumin (Synthetic)
CAS :Formule :C21H20O6Degré de pureté :>97.0%(T)Couleur et forme :Light yellow to Brown powder to crystalMasse moléculaire :368.39GW 2580
CAS :Formule :C20H22N4O3Degré de pureté :>98.0%(HPLC)Couleur et forme :White to Light yellow to Light orange powder to crystalMasse moléculaire :366.42Tyrphostin AG528
CAS :Formule :C18H14N2O3Degré de pureté :>97.0%(HPLC)Couleur et forme :Light yellow to Amber to Dark green powder to crystalMasse moléculaire :306.32Tyrphostin AG 490
CAS :Formule :C17H14N2O3Degré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :294.31Pelitinib
CAS :Formule :C24H23ClFN5O2Degré de pureté :>97.0%(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :467.93PD 153035 Hydrochloride
CAS :Formule :C16H14BrN3O2·HClDegré de pureté :>97.0%(HPLC)Couleur et forme :White to Light yellow to Light orange powder to crystalMasse moléculaire :396.67LFM-A13
CAS :Formule :C11H8Br2N2O2Degré de pureté :>98.0%(HPLC)Couleur et forme :Light yellow to Brown powder to crystalMasse moléculaire :360.01TCS 359
CAS :Formule :C18H20N2O4SDegré de pureté :>98.0%(HPLC)Couleur et forme :Light yellow to Brown powder to crystalMasse moléculaire :360.43Sorafenib
CAS :Formule :C21H16ClF3N4O3Degré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :464.83Lapatinib ditosylate monohydrate
CAS :<p>Lapatinib ditosylate monohydrate: a drug for advanced breast cancer; may cause liver issues.</p>Formule :C29H26ClFN4O4S·2(C7H8O3S)·H2ODegré de pureté :98% - 99.41%Couleur et forme :Colourless To Light-Yellow CrystalMasse moléculaire :943.47Bozitinib
CAS :<p>Bozitinib (PLB-1001) (PLB-1001) is a highly selective inhibitor of the c-MET kinase with blood-brain barrier permeability.</p>Formule :C20H15F3N8Degré de pureté :99.16%Couleur et forme :SolidMasse moléculaire :424.38Tilvestamab
CAS :<p>Tilvestamab (BGB149) is a humanized monoclonal antibody targeting AXL with anti-tumor and anti-fibrotic activities, inhibiting Gas6-induced AXL activation.</p>Degré de pureté :>95%Couleur et forme :LiquidMal-amido-PEG2-C2-amido-Ph-C2-CO-AZD
CAS :<p>Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD (PF-05231023) is a long-acting fibroblast growth factor 21 (FGF21) analog and is an FGF21-receptor agonist.</p>Formule :C26H32N4O8Degré de pureté :99.83% - >99.99%Couleur et forme :SolidMasse moléculaire :528.554-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide
CAS :Formule :C29H31N7ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :493.6027Ref: IN-DA00350H
1g25,00€5g33,00€10g56,00€1kg506,00€25g61,00€5kgÀ demander100g164,00€10kgÀ demander500g687,00€Edicotinib
CAS :<p>Edicotinib (JNJ-527) is a blood-brain permeable, selective CSF-1R inhibitor, with lesser inhibitory effects on KIT and FLT3.Cost-effective and quality-assured.</p>Formule :C27H35N5O2Degré de pureté :98.58% - 99.72%Couleur et forme :SolidMasse moléculaire :461.6Mutated EGFR-IN-1
CAS :<p>Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating</p>Formule :C25H31N7ODegré de pureté :98.91%Couleur et forme :SolidMasse moléculaire :445.564-[4-(1,3-Benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide
CAS :Formule :C22H16N4O3Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :384.38744-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide
CAS :Formule :C21H16ClF3N4O3Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :464.8249(2E)-N-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
CAS :Formule :C30H29ClN6O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :557.0427CE-245677
CAS :<p>CE-245677 is a potent reversible inhibitor of Tie2 and TrkA/B kinases. With a cellular IC50s of 4.7 and 1 nM.</p>Formule :C24H22Cl2N6O3Degré de pureté :98.99% - 99.23%Couleur et forme :SolidMasse moléculaire :513.38Tyrphostin RG 14620
CAS :Formule :C14H8Cl2N2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :275.1327FGFR1/DDR2 inhibitor 1
CAS :<p>FGFR1/DDR2 inhibitor 1 is an inhibitor of discoindin domain receptor 2 (DDR2) and fibroblast growth factor receptor 1 (FGFR1), with IC50 values of 31.1 nM, 108</p>Formule :C28H22F3N5ODegré de pureté :99.43%Couleur et forme :SolidMasse moléculaire :501.5F-1
CAS :<p>F-1: Potent ALK/ROS1 inhibitor with 2.1-3.9 nM IC50s; suppresses p-ALK signaling.</p>Formule :C22H27ClN8O3SDegré de pureté :97.66%Couleur et forme :SolidMasse moléculaire :519.02Erlotinib hydrochloride
CAS :<p>Erlotinib hydrochloride (NSC 718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.</p>Formule :C22H23N3O4·HClDegré de pureté :99.78% - 99.85%Couleur et forme :White Or Off-White PowderMasse moléculaire :429.9Quinoxaline, 6,7-dimethoxy-2-phenyl-
CAS :Formule :C16H14N2O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :266.2946Ref: IN-DA001E48
1gÀ demander1mg53,00€5mg54,00€10mg73,00€25mg107,00€50mg164,00€100mg187,00€250mg503,00€Ref: IN-DA003MZ1
1gÀ demander5gÀ demander10gÀ demander1mg47,00€25gÀ demander5mg53,00€10mg63,00€50mg171,00€100mg207,00€250mg548,00€Ref: IN-DA00AP0L
1gÀ demander1mg51,00€5mg68,00€10mg80,00€25mg102,00€50mg126,00€100mg193,00€250mg273,00€Margetuximab
CAS :<p>Margetuximab (MGAH-22) is a second generation anti-HER2 monoclonal antibody with anti-tumor activity.</p>Degré de pureté :95.3% (SDS-PAGE); 99.3% (SEC-HPLC) - 95.3% (SDS-PAGE); 99.3% (SEC-HPLC)Couleur et forme :LiquidIntetumumab
CAS :<p>Intetumumab (CNTO 95) is a fully humanized anti-α(v)-integrin monoclonal antibody that is a radiosensitizer for xenograft tumor-bearing mice.</p>Degré de pureté :97.6% (SDS-PAGE); 97.1% (SEC-HPLC) - 97.6% (SDS-PAGE); 97.1% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :145.6 (kDa)Axatilimab
CAS :<p>Axatilimab (SNDX-6352) is a human IgG4 antibody that targets CSF-1R and can be used to study immune system diseases and respiratory diseases.</p>Degré de pureté :97.9% (SDS-PAGE); 97% (SEC-HPLC) - 97.9% (SDS-PAGE); 97% (SEC-HPLC)Couleur et forme :LiquidN-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2-yl)quinazolin-4-amine
CAS :Formule :C29H26ClFN4O4SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :581.0575Ref: IN-DA0039KT
1g106,00€5g222,00€50g573,00€100gÀ demander250gÀ demander25mg29,00€100mg44,00€250mg56,00€1,3-Benzodioxole, 5-(2-nitroethenyl)-
CAS :Formule :C9H7NO4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :193.1562Dasatinib monohydrate
CAS :<p>Dasatinib monohydrate, an oral SRC-kinase inhibitor, counters imatinib-resistant chronic myeloid leukemia.</p>Formule :C22H28ClN7O3SDegré de pureté :99.68% - >99.99%Couleur et forme :SolidMasse moléculaire :506.03GSK-626616
CAS :<p>GSK-626616: strong, oral DYRK3 inhibitor (IC50: 0.7 nM), affects DYRK family, may treat anemia.</p>Formule :C18H10Cl2N4OSDegré de pureté :98.27%Couleur et forme :SolidMasse moléculaire :401.272-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]-
CAS :Formule :C18H13BrN4ODegré de pureté :97%Couleur et forme :SolidMasse moléculaire :381.2260Panitumumab
CAS :<p>Panitumumab is a fully human IgG2 monoclonal antibody targeting the epidermal growth factor receptor EGFR).</p>Degré de pureté :95% - 98.1% (SDS-PAGE); 99.4% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :147 kDaGIP (3-42), human
CAS :<p>Human GIP (3-42) is a peptide antagonist of GIP receptors, affecting insulin regulation and diabetes research.</p>Formule :C214H324N58O63SDegré de pureté :95.73%Couleur et forme :SolidMasse moléculaire :4749.35Pyrotinib dimaleate
CAS :<p>Pyrotinib dimaleate is a selective EGFR/HER2 dual inhibitor, respectively, for the treatment of HER2-positive breast cancer.Cost-effective and quality-assured.</p>Formule :C40H39ClN6O11Degré de pureté :97.27% - 99.52%Couleur et forme :SolidMasse moléculaire :815.224-Quinazolinamine, N-(3-chlorophenyl)-6,7-dimethoxy-
CAS :Formule :C16H14ClN3O2Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :315.7543Gancotamab
CAS :<p>Gancotamab (MM-302) is a polyethylene glycolated liposome targeting HER2 with antitumor activity for the study of advanced HER2-positive breast cancer.</p>Degré de pureté :96.7% (SDS-PAGE); 98.4% (SEC-HPLC) - 96.7% (SDS-PAGE); 98.4% (SEC-HPLC)Couleur et forme :Liquid1-[4-[4-[[2-[(1E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-1H-1,2,3-triazole
CAS :Formule :C25H23F3N4O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :468.4709Imatinib mesylate
CAS :Formule :C30H35N7O4SDegré de pureté :99%Couleur et forme :SolidMasse moléculaire :589.70844H-1-Benzopyran-4-one, 5,7-dihydroxy-3-(4-hydroxyphenyl)-
CAS :Formule :C15H10O5Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :270.2369Ref: IN-DA00I8G3
1g26,00€5g24,00€10g31,00€1kg686,00€25g52,00€50g77,00€5kgÀ demander100g114,00€10kgÀ demander250g181,00€500g320,00€100mg26,00€(E)-2-Cyano-3-(4-hydroxy-3,5-diisopropylphenyl)-N-(3-phenylpropyl)acrylamide
CAS :Formule :C25H30N2O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :390.51792-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride
CAS :Formule :C20H21N3O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :335.39962H-1-Benzopyran-2-one, 7,8-dihydroxy-
CAS :Formule :C9H6O4Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :178.1415(E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide
CAS :Formule :C17H14N2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :294.30472H-Indol-2-one, 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-
CAS :Formule :C15H14N2ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :238.2845AG-528
CAS :Formule :C18H14N2O3Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :306.3154Axitinib
CAS :<p>Axitinib (AG-013736) is a multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1/2/3 and PDGFRβ. Axitinib has antitumor activity. Cost-effective and quality-assured.</p>Formule :C22H18N4OSDegré de pureté :98.9% - 99.74%Couleur et forme :Off-White SolidMasse moléculaire :386.47(2E)-2-Cyano-3-(3,4-dihydroxyphenyl)-N-[(1S)-1-phenylethyl]-2-propenamide
CAS :Formule :C18H16N2O3Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :308.3312Propanedinitrile,2-[(4-methoxyphenyl)methylene]-
CAS :Formule :C11H8N2ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :184.19402-Butenamide, 2-cyano-N-(2,5-dibromophenyl)-3-hydroxy-
CAS :Formule :C11H8Br2N2O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :360.0014AS-1763
CAS :<p>AS-1763 is an orally available and selective BTK inhibitor with an IC50 of 0.85 nM.</p>Formule :C33H31FN6O3Degré de pureté :≥95%Couleur et forme :SolidMasse moléculaire :578.64Pazopanib
CAS :<p>Pazopanib (GW786034) is an inhibitor of protein tyrosine kinases that inhibits VEGFR1/2/3. Pazopanib has antitumor activity. Cost-effective and quality-assured.</p>Formule :C21H23N7O2SDegré de pureté :98.78% - 99.85%Couleur et forme :White PowderMasse moléculaire :437.52Orelabrutinib
CAS :<p>Orelabrutinib (ICP-022) is an orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK).</p>Formule :C26H25N3O3Degré de pureté :97.77% - 99.54%Couleur et forme :SolidMasse moléculaire :427.49GIP (human) acetate
<p>GIP (human) acetate boosts insulin, limits gastric acid, affects lipid metabolism, and obesity development.</p>Degré de pureté :98.65%Couleur et forme :SoildSKLB1002
CAS :Formule :C13H12N4O2S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :320.3900PD 173074
CAS :Formule :C28H41N7O3Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :523.67022-(3,4-Dimethoxyphenylcarbamoyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
CAS :Formule :C18H20N2O4SDegré de pureté :95%Couleur et forme :SolidMasse moléculaire :360.4274(2E)-2-Cyano-3-(3,5-di-tert-butyl-4-hydroxyphenyl)prop-2-enethioamide
CAS :Formule :C18H24N2OSDegré de pureté :95%Couleur et forme :SolidMasse moléculaire :316.4610Dasatinib
CAS :<p>Dasatinib (BMS-354825) is a tyrosine kinase inhibitor that inhibits Src and Bcr-Abl (Ki=16/30 pM) and is orally active and ATP-competitive.</p>Formule :C22H26ClN7O2SDegré de pureté :99.59% - 99.86%Couleur et forme :Pale-Yellow SolidMasse moléculaire :488.014-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)
CAS :Formule :C22H23ClN3O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :429.8967N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine
CAS :Formule :C22H24ClFN4O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :446.9024Barecetamab
CAS :<p>Barecetamab (ISU-104) is a humanized monoclonal antibody against tyrosine protein kinase ErbB3 with anticancer activity.</p>Degré de pureté :97.1% (SDS-PAGE); 96.4% (SEC-HPLC) - 97.1% (SDS-PAGE); 96.4% (SEC-HPLC)Couleur et forme :LiquidWHI-P154
CAS :Formule :C16H14BrN3O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :376.2047Methyl 2,5-Dihydroxycinnamate
CAS :Formule :C10H10O4Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :194.18401,2-Benzenediol, 4-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]-
CAS :Formule :C14H12O4Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :244.2427JNJ-38877618
CAS :<p>JNJ-38877618 (OMO-1) is an effective and highly selective inhibitor of Met kinase (IC50s: 2 and 3 nM for wild type and mutant Met, respectively).</p>Formule :C20H12F2N6Degré de pureté :98.84% - 99.74%Couleur et forme :SolidMasse moléculaire :374.35AG 1295
CAS :<p>AG 1295 is a selective PDGFR tyrosine-kinase inhibitor; it blocks PDGFR autophosphorylation without affecting EGF receptor.</p>Formule :C16H14N2Degré de pureté :99.64%Couleur et forme :SolidMasse moléculaire :234.3Erlotinib
CAS :<p>Erlotinib (NSC-718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.</p>Formule :C22H23N3O4Degré de pureté :98.19% - 99.98%Couleur et forme :White To Off-White PowderMasse moléculaire :393.44TYRPHOSTIN B48
CAS :Formule :C16H12N2O3Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :280.2781IBT6A
CAS :<p>IBT6A is an impurity of Ibrutinib. Ibrutinib is a Btk inhibitor (IC50: 0.5 nM). IBT6A can be used in the synthesis of IBT6A Ibrutinib dimer and IBT6A adduct.</p>Formule :C22H22N6ODegré de pureté :99.8% - 99.88%Couleur et forme :SolidMasse moléculaire :386.45FLT3-IN-3
CAS :<p>FLT3-IN-3 is an effective FLT3 inhibitor, and the IC50s of FLT3 WT and FLT3 D835Y are 13 and 8 nM, respectively.</p>Formule :C27H38N8ODegré de pureté :99.25%Couleur et forme :SolidMasse moléculaire :490.64Epertinib hydrochloride
CAS :<p>Epertinib hydrochloride (S-22611 hydrochloride) shows potent antitumor activity.</p>Formule :C30H28Cl2FN5O3Degré de pureté :99.14%Couleur et forme :SolidMasse moléculaire :596.48Khellin
CAS :<p>Khellin (Methafrone) is a vasodilator that also has bronchodilatory action.</p>Formule :C14H12O5Degré de pureté :99.89% - 99.95%Couleur et forme :Light Yellow CrystallineMasse moléculaire :260.24Hck-IN-1
CAS :<p>Hck-IN-1 selectively inhibits Nef:Hck, IC50: 2.8 μM; >20 μM for Hck alone. Potent HIV-1 Nef antagonist, IC50: 100-300 nM for HIV-1 replication.</p>Formule :C16H11ClN6O3SDegré de pureté :99.07%Couleur et forme :SolidMasse moléculaire :402.81Lacnotuzumab
CAS :<p>Lacnotuzumab (MCS110) is a humanized monoclonal antibody targeting CSF-1, which can be used in research on retinal diseases.</p>Degré de pureté :>95%Couleur et forme :LiquidLapatinib
CAS :<p>Lapatinib (GW572016) is an inhibitor of ErbB2 and EGFR (IC50=9.2/10.8 nM) with oral activity.</p>Formule :C29H26ClFN4O4SDegré de pureté :99.00% - 99.81%Couleur et forme :PowderMasse moléculaire :581.06JNJ-10198409
CAS :<p>JNJ-10198409: selective ATP competitive PDGF-RTK inhibitor; IC50: PDGFR-β 4.2 nM, PDGFR-α 45 nM; antiangiogenic & antiproliferative.</p>Formule :C18H16FN3O2Degré de pureté :98.51%Couleur et forme :SolidMasse moléculaire :325.34Mevastatin
CAS :<p>Mevastatin (ML236B) is an HMG-CoA reductase inhibitor that was initially isolated from the mold Pythium ultimum.</p>Formule :C23H34O5Degré de pureté :99.12%Couleur et forme :White-Yellowish To Yellow Powder Solid PowderMasse moléculaire :390.51Rilotumumab
CAS :<p>Rilotumumab (AMG 102) is an HGF-targeting antibody, inhibits HGF/MET signaling, and is used for CRPC and gastric cancer research.</p>Degré de pureté :SDS-PAGE:95% SEC-HPLC:97.51%Couleur et forme :LiquidMasse moléculaire :145.2 kDaCSF1R-IN-1
CAS :<p>CSF1R-IN-1 is a CSF1R inhibitor with IC50 of 0.5 nM.</p>Formule :C25H20F3N5O2Degré de pureté :97.02% - 98.56%Couleur et forme :SolidMasse moléculaire :479.45CEP-28122 mesylate salt (1022958-60-6 free base)
<p>CEP-28122 mesylate salt (1022958-60-6 free base) is a highly selective orally active ALK inhibitor (IC50: 1.9 nM in an enzyme-based TRF assay).</p>Formule :C29H39ClN6O6SDegré de pureté :99.79%Couleur et forme :SolidMasse moléculaire :635.17c-Met inhibitor 1
CAS :<p>c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of cancer including glioblastoma, gastric, and pancreatic cancer.</p>Formule :C17H14N8SDegré de pureté :98.77%Couleur et forme :SolidMasse moléculaire :362.41Ganitumab
CAS :<p>Ganitumab (AMG 479) is a potent monoclonal antibody targeting IGF1R with 0.22 nM affinity; used in cancer research.</p>Degré de pureté :100% (SEC-HPLC) - > 95%Couleur et forme :LiquidMasse moléculaire :145.70 kDaAZ7550 hydrochloride
CAS :<p>AZ7550 hydrochloride (AZ7550 hydrochloride ), an active metabolite of AZD9291, inhibits the activity of IGF1R (IC50: 1.6 μM).</p>Formule :C27H32ClN7O2Degré de pureté :99.65%Couleur et forme :SolidMasse moléculaire :522.04GW2580
CAS :Formule :C20H22N4O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :366.4137LCH-7749944
CAS :<p>LCH-7749944 suppresses human gastric cancer cell growth, induces apoptosis, and inhibits PAK4 with IC50 of 14.93 μM.</p>Formule :C20H22N4O2Degré de pureté :99.48%Couleur et forme :SolidMasse moléculaire :350.41Emibetuzumab
CAS :<p>Emibetuzumab: potent humanized MET antibody, antitumor, inhibits HGF/MET pathways, for advanced prostate cancer research.</p>Degré de pureté :SDS-PAGE:96.2%;SEC-HPLC:98.8%Couleur et forme :LiquidMasse moléculaire :143.74 kDaO-Desmethyl gefitinib
CAS :<p>O-Desmethyl gefitinib is an active EGFR inhibitor (IC50: 36 nM), a metabolite of Gefitinib, formed by CYP2D6.</p>Formule :C21H22ClFN4O3Degré de pureté :97.17%Couleur et forme :SolidMasse moléculaire :432.882-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-
CAS :Formule :C21H15ClF4N4O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :482.8154Ref: IN-DA00ICN3
1g131,00€5g255,00€10g619,00€50g617,00€100gÀ demander10mg30,00€50mg46,00€100mg56,00€250mg69,00€500mg100,00€Petosemtamab
CAS :<p>Petosemtamab (MCLA 158), a dual-action monoclonal antibody targets EGFR & LGR5, used in solid tumor research like HNSCC & CRC.</p>Degré de pureté :> 95% - > 95%Couleur et forme :LiquidMasse moléculaire :145.97 kDaRilzabrutinib
CAS :<p>Rilzabrutinib (PRN1008) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK)(IC50 of 1.3 nM).</p>Formule :C36H40FN9O3Degré de pureté :98.28% - 99.76%Couleur et forme :SolidMasse moléculaire :665.76Adrenalone hydrochloride
CAS :<p>Adrenalone HCl: α1-adrenoceptor agonist, topical hemostatic, vasoconstrictor, prolongs local anesthesia.</p>Formule :C9H11NO3·HClDegré de pureté :99.94%Couleur et forme :SolidMasse moléculaire :217.65Gefitinib
CAS :<p>Gefitinib (ZD1839) is an EGFR first-generation inhibitor with oral activity that inhibits the EGFR 19 Del and L858R mutations.</p>Formule :C22H24ClFN4O3Degré de pureté :99.92% - >99.99%Couleur et forme :Light-Yellow Crystalline PowderMasse moléculaire :446.9Ilginatinib
CAS :<p>Ilginatinib (NS-018) is a highly active and orally bioavailable inhibitor of JAK2.</p>Formule :C21H20FN7Degré de pureté :98.4% - 99.01%Couleur et forme :SolidMasse moléculaire :389.43Rociletinib
CAS :<p>Rociletinib (CNX-419) is an orally available small molecule, irreversible inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic</p>Formule :C27H28F3N7O3Degré de pureté :98.52% - 99.25%Couleur et forme :SolidMasse moléculaire :555.55Lucitanib
CAS :<p>Lucitanib (E-3810) is a VEGFR/FGFR inhibitor targeting VEGFR1-3 and FGFR1-2 with IC50s 7-82.5 nM.</p>Formule :C26H25N3O4Degré de pureté :96.13%Couleur et forme :SolidMasse moléculaire :443.49Tyrphostin RG 13022
CAS :Formule :C16H14N2O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :266.2946Losatuxizumab
CAS :<p>Losatuxizumab (ABT-806) is an anti-EGFR monoclonal antibody with potential anti-tumor activity for the study of advanced malignant solid tumors.</p>Degré de pureté :97.3% (SDS-PAGE); 95.1% (SEC-HPLC) - 97.3% (SDS-PAGE); 95.1% (SEC-HPLC)Couleur et forme :LiquidLapatinib Ditosylate
CAS :<p>Lapatinib Ditosylate (Tykerb ditosylate) is an effective EGFR and ErbB2 inhibitor (IC50: 10.8/9.2 nM for EGFR/ErbB2).</p>Formule :C29H26ClFN4O4S·2C7H8O3SDegré de pureté :99.41%Couleur et forme :Yellow SolidMasse moléculaire :925.46TAM-IN-2
CAS :<p>TAM-IN-2 is an inhibitor of TAM.</p>Formule :C31H27F2N7O3Degré de pureté :98.09% - 99.74%Couleur et forme :SolidMasse moléculaire :583.59AV-412
CAS :<p>AV-412 (MP412) is an EGFR inhibitor (EGFR, EGFR T790M, EGFR L858R, EGFR L858R/T790M and ErbB2 with IC50s of 0.75, 0.79, 0.5, 2.3, 19 nM).</p>Formule :C41H44ClFN6O7S2Degré de pureté :99.85% - 99.92%Couleur et forme :SolidMasse moléculaire :851.41Robatumumab
CAS :<p>Robatumumab (Sch 717454) is a fully humanized anti-IGF-1R monoclonal antibody with antitumor activity and antiproliferative activity.</p>Degré de pureté :96.9% (SDS-PAGE); 98.1% (SEC-HPLC) - 96.9% (SDS-PAGE); 98.1% (SEC-HPLC)Couleur et forme :LiquidBosutinib
CAS :<p>Bosutinib (SKI-606) is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl (IC50: 1 nM) and Src (IC50: 1.2 nM) kinases.</p>Formule :C26H29Cl2N5O3Degré de pureté :98.98% - 99.9%Couleur et forme :Yellowish-Orange Or Pink To Brownish Solid Solid PowderMasse moléculaire :530.45Lanraplenib
CAS :<p>Lanraplenib (GS-9876) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.</p>Formule :C23H25N9ODegré de pureté :98.35%Couleur et forme :SolidMasse moléculaire :443.5ARQ 531
CAS :<p>ARQ-531: potent oral BTK inhibitor, anti-cancer potential, IC50 of 0.85/0.39 nM for WT/C481S-BTK.</p>Formule :C25H23ClN4O4Degré de pureté :98.68% - 99.63%Couleur et forme :SolidMasse moléculaire :478.93CSF1R-IN-2
CAS :<p>CSF1R-IN-2 is an oral-active SRC, MET and c-FMS inhibitor (IC50s: 0.12 nM, 0.14 nM and 0.76 nM for SRC, MET and c-FMS respectively).</p>Formule :C20H20FN7O2Degré de pureté :99.29%Couleur et forme :SolidMasse moléculaire :409.42Btk inhibitor 2
CAS :<p>Btk inhibitor 2 (BGB-3111 analog) is a BTK inhibitor.</p>Formule :C24H25N5O3Degré de pureté :99.94%Couleur et forme :SolidMasse moléculaire :431.49Bucladesine sodium
CAS :<p>Bucladesine sodium (DC2797) is a cAMP analog with cell-permeable properties.</p>Formule :C18H23N5NaO8PDegré de pureté :96.56% - 99.76%Couleur et forme :White PowderMasse moléculaire :491.37Ilginatinib maleate
CAS :<p>Ilginatinib maleate (NS-018 maleate) is a highly active and orally bioavailable inhibitor of JAK2.</p>Formule :C25H24FN7O4Degré de pureté :99.74% - 99.82%Couleur et forme :SolidMasse moléculaire :505.5Delgocitinib
CAS :<p>Delgocitinib is a potent JAK inhibitor (IC50: 2.8-58 nM), treats inflammatory diseases, and is the first topical drug for atopic dermatitis.</p>Formule :C16H18N6ODegré de pureté :99.95%Couleur et forme :SolidMasse moléculaire :310.35MRX-2843
CAS :<p>MRX-2843 (UNC2371) is a potent and orally active inhibitor of MERTK and FLT3(IC50s of 1.3 nM and 0.64 nM, respectively).</p>Formule :C29H40N6ODegré de pureté :98.59% - 99.63%Couleur et forme :SolidMasse moléculaire :488.67Tirbanibulin Mesylate
CAS :<p>Tirbanibulin Mesylate (KX01 Mesylate) is an inhibitor of Src that targets the peptide substrate site of Src (GI50: 9-60 nM in cancer cell lines).</p>Formule :C27H33N3O6SDegré de pureté :99%Couleur et forme :SolidMasse moléculaire :527.63Onartuzumab
CAS :<p>Onartuzumab (MetMAb) is a humanized monoclonal antibody targeting c-MET, with antitumor effects by blocking HGF and signal transduction.</p>Degré de pureté :97.3%Couleur et forme :LiquidMasse moléculaire :146.99 kDaAZ-Dyrk1B-33
CAS :<p>AZ-Dyrk1B-33 (3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine) is a potent and selective Dyrk1B kinase inhibitor with an IC50 of 7 nM.</p>Formule :C19H16N4Degré de pureté :99.91%Couleur et forme :SolidMasse moléculaire :300.36Emactuzumab
CAS :<p>Emactuzumab(RG 7155) is a monoclonal antibody against colony-stimulating factor-1 receptor targeting tumor-associated macrophages (TAMs) Emactuzumab has</p>Degré de pureté :SDS-PAGE:98.3%;SEC-HPLC:97.3%Couleur et forme :LiquidMasse moléculaire :144.4 kDaAllitinib
CAS :<p>Allitinib (AST-1306) (AST-1306) has anti-cancer activity，and it is an irreversible EGFR and ErbB2 inhibitor with IC50s of 0.5 and 3 nM, respectively. [1]</p>Formule :C24H18ClFN4O2Degré de pureté :99.89% - 99.91%Couleur et forme :SolidMasse moléculaire :448.88Duligotuzumab
CAS :<p>Duligotuzumab is a dual-targeting anti-EGFR/HER3 mAb that blocks signaling and induces ADCC for tumors with poor prognosis.</p>Degré de pureté :95% - 95%Couleur et forme :LiquidBLU-945
CAS :<p>BLU-945 is a reversible, potent, highly selective, and orally available epidermal growth factor receptor tyrosine kinase inhibitor (TKIs).Cost-effective and quality-assured.</p>Formule :C28H37FN6O3SDegré de pureté :99.11% - 99.16%Couleur et forme :SolidMasse moléculaire :556.7LMTK3-IN-1
CAS :<p>Lmtk3-in-1 is a potent ATP-competitive lemur tyrosine kinase 3 (LMTK3) (Kd=2.5 μM) inhibitor that degrades LMTK3 through the ubiquitin proteasome pathway.</p>Formule :C18H11F3N4ODegré de pureté :99.89%Couleur et forme :SoildMasse moléculaire :356.3Compound TPX-0046
CAS :<p>Compound TPX-0046 is an inhibitor of RET. Compound TPX-0046 can inhibit the RET autophosphorylation. Compound TPX-0046 can be used for the research of cancer.</p>Formule :C21H21FN6O3Degré de pureté :99.94%Couleur et forme :SoildMasse moléculaire :424.43Gefitinib N-oxide hydrochloride
<p>Gefitinib N-oxide hydrochloride is an N-oxide of EGFR inhibitor Gefitinib with IC50 of 2-37 nM.</p>Formule :C22H24ClFN4O41·5HClCouleur et forme :SolidMasse moléculaire :517.59Eflapegrastim
CAS :<p>Eflapegrastim: humanized IgG4 antibody and G-CSF that boosts neutrophils and shortens neutropenia.</p>Couleur et forme :LiquidTimigutuzumab
CAS :<p>Timigutuzumab (GEXMab73) is a humanized monoclonal antibody designed to target ErbB2, showing potential application in cancer research [1].</p>Couleur et forme :LiquidKinase Inhibitor Library
<p>A unique collection of 2720 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;</p>Couleur et forme :Odour SolidZenocutuzumab
CAS :<p>Zenocutuzumab (MCLA-128) is a humanized antibody targeting HER2, used for research on tumors driven by NRG1 gene rearrangement.</p>Degré de pureté :97%Couleur et forme :LiquidPF-04217903 phenolsulfonate
CAS :<p>PF-04217903 phenolsulfonate is a potent ATP-competitive inhibitor of c-Met kinase (Ki of 4.8 nM for human c-Met).</p>Formule :C25H22N8O5SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :546.56(Pro3) GIP, human
CAS :<p>(Pro3) GIP, human: stable hGIPR full agonist, high affinity (Ki/Kd=0.90nM), for obesity-related diabetes research.</p>Formule :C226H338N60O64SCouleur et forme :SolidMasse moléculaire :4951.53HER2-IN-13
CAS :<p>HER2-IN-13 (Compound 33) serves as an effective HER2 inhibitor, exhibiting an IC50 value of 8 nM, and additionally demonstrates inhibition of wt-EGFR with an</p>Formule :C26H23ClF2N8O3Couleur et forme :SolidMasse moléculaire :568.96EGFR-IN-76
CAS :<p>EGFR-IN-76 is a potent EGFR inhibitor.</p>Formule :C30H30ClFN6O2Degré de pureté :97.02% - 97.72%Couleur et forme :SolidMasse moléculaire :561.05MS9449
CAS :<p>MS9449 is a powerful EGFR PROTAC; Kd: 17 nM (WT), 10 nM (L858R); targets mutant EGFRs via UPS and autophagy; hinders NSCLC cell growth.</p>Formule :C60H76ClFN10O8SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :1151.82Nuzefatide
CAS :<p>Nuzefatide is a peptide that binds to liver protein receptors.</p>Formule :C105H162N32O27S3Couleur et forme :SolidMasse moléculaire :2400.80JBJ-09-063 TFA
<p>JBJ-09-063 TFA, an EGFR inhibitor selective for EGFR mutations, IC50s: 0.147-0.396 nM, blocks EGFR/Akt/ERK signaling, for EGFR-mutant lung cancer research.</p>Formule :C33H30F4N4O5SCouleur et forme :SolidMasse moléculaire :670.67Acrizanib
CAS :<p>Acrizanib (LHA510) is a VEGFR-2 inhibitor, with an IC50 of 17.4 nM for BaF3-VEGFR-2.</p>Formule :C20H18F3N7O2Degré de pureté :98.71% - 99.64%Couleur et forme :SolidMasse moléculaire :445.4BMS-599626 2HCL(714971-09-2 Free base)
CAS :<p>BMS-599626 2HCL (AC480 2HCl) is a BMS-599626 derivative.</p>Formule :C27H29Cl2FN8O3Degré de pureté :99.11%Couleur et forme :Odour SolidMasse moléculaire :603.47KT5720
CAS :<p>KT5720 is a cell-permeable, reversible, and ATP-competitive inhibitor of protein kinase A (PKA) (Ki: 60 nM).</p>Formule :C32H31N3O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :537.61EGFR-IN-42
<p>EGFR-IN-42 (17b) is a potent EGFR inhibitor with nanomolar efficacy, merging tamoxifen/endoxifen and gefitinib, exhibiting enhanced anti-cancer action.</p>Formule :C49H53ClFN5O5Couleur et forme :SolidMasse moléculaire :846.43Kemptide Phospho-Ser5
<p>Kemptide (Phospho-Ser5) is a phosphoreceptor peptide that is a specific substrate for camp-dependent protein kinase (PKA).</p>Formule :C32H62N13O12PDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :851.89Insulin peglispro
CAS :<p>Insulin peglispro (BIL) is a basal insulin with a stable, extended activity and may offer improved blood sugar control.</p>Formule :C370H566N104O110S4Couleur et forme :SolidMasse moléculaire :8359.32PKG Substrate
CAS :<p>PKG Substrate is selective for PKG, favors PKG Iα (Km=59µM) over PKG II (Km=305µM).</p>Formule :C35H67N17O11Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :902.01ALW-II-49-7
CAS :<p>ALW-II-49-7 is a selective and potent inhibitor of EphB2 kinase with an EC50 value of 40 nM in cell.</p>Formule :C21H17F3N4O2Degré de pureté :99.72%Couleur et forme :SoildMasse moléculaire :414.38Istiratumab
CAS :<p>Istiratumab (M-6495) is a bispecific antibody against IGF-1R/ErbB3 for cancer research, promoting receptor degradation.</p>Couleur et forme :LiquidTyrosine Kinase Inhibitor Library
<p>A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related</p>Couleur et forme :Odour SolidHER2-IN-14
CAS :<p>HER2-IN-14 (Compound 34) is a potent inhibitor of HER2, achieving an inhibitory concentration (IC50) of 18 nM.</p>Formule :C26H23ClF2N8O3Couleur et forme :SolidMasse moléculaire :568.96GNF-8625 monopyridin-N-piperazine hydrochloride
CAS :<p>GNF-8625 monopyridin-N-piperazine hydrochloride is a protomyosin receptor kinase (TRK) inhibitor.</p>Formule :C25H27ClFN7Degré de pureté :98.97%Couleur et forme :SolidMasse moléculaire :479.98MC-Val-Cit-PAB-Amide-TLR7 agonist 4 Conjugate
CAS :<p>MC-Val-Cit-PAB-Amide-TLR7 agonist 4 Conjugate is a conjugate formed by linking MC-Val-Cit-PAB-Amide and TLR7 agonist 4, useful for cancer research.</p>Formule :C52H72N12O11Degré de pureté :97.70%Couleur et forme :SolidMasse moléculaire :1041.2EGFR-IN-15
CAS :<p>EGFR-IN-15 (compound I-005) is a potent EGFR inhibitor, exhibiting an IC50 value of 4 nM. This compound holds potential for oncological research applications.</p>Formule :C24H25BrN6O2Couleur et forme :SolidMasse moléculaire :509.408Valanafusp alfa
CAS :<p>Valanafusp alfa (AGT-181) is a fusion protein targeting HIR and IDUA for MPS I research.</p>Couleur et forme :LiquidAcetyl Gastric Inhibitory Peptide (human)
CAS :<p>Acetyl Gastric Inhibitory Peptide: improved insulinotropic, antihyperglycemic, for diabetes/obesity research.</p>Formule :C228H340N60O67SCouleur et forme :SolidMasse moléculaire :5025.6EGFR-IN-43
<p>EGFR-IN-43 (17c) is a potent EGFR inhibitor with ER antagonist action, tamoxifen/endoxifen+gefitinib linkage, and strong anticancer activity.</p>Formule :C50H55ClFN5O5Couleur et forme :SolidMasse moléculaire :860.45WAY-270250
CAS :<p>WAY-270250 is an IGF-1R/SRC inhibitor.</p>Formule :C18H16N2O2Degré de pureté :99.77%Couleur et forme :SoildMasse moléculaire :292.33Macupatide
CAS :<p>Macupatide is a gastric inhibitory polypeptide (GIP) receptor agonist, utilized in research related to antidiabetic applications.</p>Couleur et forme :SolidIGF-I (24-41)
CAS :<p>IGF-I (24-41) is a fragment of IGF-I, affecting GH activities with anabolic, antioxidant, anti-inflammatory, and cytoprotective properties.</p>Formule :C88H133N27O28Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :2017.16FDA-Approved Kinase Inhibitor Library
<p>A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.</p>Couleur et forme :LiquidLyso-Monosialoganglioside GM3
CAS :<p>Lyso-Monosialoganglioside GM3 (Lyso-GM3) is an analog of Ganglioside GM3 with antitumor properties. It inhibits the increase in EGFR kinase activity induced by EGF in A431 epithelial cancer cells.</p>Formule :C41H74N2O20Couleur et forme :SolidMasse moléculaire :915.028BMS-777607
CAS :<p>BMS-777607 is a Met-related inhibitor for c-Met, Axl, Ron and Tyro3.</p>Formule :C25H19ClF2N4O4Degré de pureté :98.16% - 98.56%Couleur et forme :SolidMasse moléculaire :512.89GIP (1-30) amide,human
CAS :<p>GIP (1-30) amide (Human) is a glucose-dependent insulinotropic polypeptide that stimulates insulin secretion, reducing postprandial glycemic issues.</p>Formule :C162H240N40O47SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :3531.94Varlitinib Tosylate
CAS :<p>Varlitinib Tosylate is a selective and potent inhibitor of ErbB1(EGFR) and ErbB2(HER2).</p>Formule :C36H35ClN6O8S3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :811.34Pertuzumab
CAS :<p>Pertuzumab (anti-HER2) a humanized monoclonal antibody and the first in the class of agents called the HER2 dimerization inhibitors impairs the ability of HER2</p>Degré de pureté :98.00%Couleur et forme :LiquidMasse moléculaire :148 kDaGIP (1-30) amide, porcine TFA
<p>GIP (1-30) amide, porcine TFA: a full GIP receptor agonist, similar to natural GIP(1-42), stimulates insulin, mildly inhibits gastric acid.</p>Couleur et forme :LiquidDA-JC4
CAS :<p>DA-JC4: dual GLP-1/GIP agonist, for neurological disease research and insulin pathway studies.</p>Formule :C225H346N56O65Couleur et forme :SolidMasse moléculaire :4875.49Cixutumumab
CAS :<p>Cixutumumab (IMC-A12), a humanized monoclonal antibody targeting IGF-1R, exhibits high affinity and inhibits ligand-dependent receptor activation, impeding</p>Degré de pureté :98.5% (SDS-PAGE); 97.5% (SEC-HPLC) - 98.5% (SDS-PAGE); 97.5% (SEC-HPLC)Couleur et forme :LiquidMS9427
CAS :<p>MS9427: PROTAC EGFR degrader, 7.1 nM (WT), 4.3 nM (L858R); targets mutant via UPS and autophagy; inhibits NSCLC cell growth; anticancer research.</p>Formule :C48H58ClFN8O12Couleur et forme :SolidMasse moléculaire :993.47HER2/neu (654-662) GP2
CAS :<p>Phage display selected Affibody ligands for HER2/neu from a protein library based on a 58-residue Staphylococcal protein A Z domain.</p>Formule :C42H77N9O11Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :884.11CREBtide
CAS :<p>CREBtide is a synthetic substrate for PKA (Km=3.9 µM), which is based on the phosphorylation sequence in d-CREB (cAMP response element binding protein).</p>Formule :C73H129N29O19Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1716.99KN1022
CAS :<p>KN1022 is an inhibitor of phosphorylation of platelet-derived growth factor (PDGF) receptor with IC50 of 0.26 μM.</p>Formule :C21H22N6O5Degré de pureté :99.68%Couleur et forme :SoildMasse moléculaire :438.44JAK 3 inhibitor IV
CAS :<p>JAK 3 inhibitor IV (ZM 39923 hydrochloride) is a JAK1/3 inhibitor with pIC50 of 4.4/7.1, almost no activity to JAK2 and modestly potent to EGFR; also found to</p>Formule :C16H19NODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :241.33ALKBH5-IN-5
CAS :<p>ALKBH5-IN-5 is a highly selective, potent and covalently binding ALKBH5 inhibitor that alters m6A levels on mRNA, induces apoptosis, antitumo.</p>Formule :C13H13NO3Degré de pureté :99.54%Couleur et forme :SoildMasse moléculaire :231.25FLT3-ITD-IN-2
<p>FLT3-ITD-IN-2 (Compound A1) is an inhibitor of the FLT3-ITD kinase, exhibiting an IC50 of 2.12 nM. It effectively suppresses the proliferation of the FLT3-dependent human AML cell line MOLM-13, with an IC50 of 25.65 nM. FLT3-ITD-IN-2 demonstrates antitumor activity against acute myeloid leukemia.</p>Formule :C39H50N8O6Couleur et forme :SolidMasse moléculaire :726.86DSPE-PEG2000-GE11
<p>DSPE-PEG2000-GE11 is a PEG compound composed of DSPE and an EGFR-targeting peptide (GE11). GE11 is applicable for cancer cells that overexpress EGFR. DSPE-PEG2000-GE11 is utilized in drug delivery.</p>Couleur et forme :Odour SolidPKG inhibitor peptide
CAS :<p>PKG inhibitor; mimics H2B phosphorylation site; Ki=86mM; blocks synthetic substrates, not histone phosphorylation; stops PKA activity on histones.</p>Formule :C38H74N18O10Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :943.12KYL peptide
CAS :<p>EphA4 inhibitor, Kd 0.8 μM, blocks EphA4-EphrinA5; avoids AβO damage, preserves spines & LTP; long half-life (8-12h), neuroprotective.</p>Formule :C74H108N14O17Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1465.75Gastric Inhibitory Peptide (1-42) (porcine) TFA
<p>Gastric Inhibitory Peptide (1-42) (porcine) TFA is a glucose-dependent insulinotropic polypeptide released by intestinal K-cells.</p>Formule :C225H342N60O66S·XCF3COOHCouleur et forme :SolidMasse moléculaire :4975.55Tephrosin
CAS :<p>Tephrosin induces degradation of of EGFR and ErbB2 by inducing internalization of the receptors, has potent antitumor activities.</p>Formule :C23H22O7Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :410.42PROTAC EGFR degrader 2
<p>Potent PROTAC EGFR degrader 2; IC50: 4.0 nM, DC50: 36.51 nM; inhibits cell growth; for NTR-responsive synthesis.</p>Formule :C58H72ClFN12O8SCouleur et forme :SolidMasse moléculaire :1151.78
![4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benz…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00350H.webp&w=3840&q=75)
![4-[4-(1,3-Benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0037OO.webp&w=3840&q=75)
![4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0039KS.webp&w=3840&q=75)
![(2E)-N-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimeth…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0035DM.webp&w=3840&q=75)
![N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0039KT.webp&w=3840&q=75)
![2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00ABJJ.webp&w=3840&q=75)
![1-[4-[4-[[2-[(1E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-1H-1,2,3-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0078T8.webp&w=3840&q=75)
![2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00FC10.webp&w=3840&q=75)
![2H-Indol-2-one, 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00298W.webp&w=3840&q=75)
![(2E)-2-Cyano-3-(3,4-dihydroxyphenyl)-N-[(1S)-1-phenylethyl]-2-propenamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA003988.webp&w=3840&q=75)
![Propanedinitrile,2-[(4-methoxyphenyl)methylene]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA007L0Q.webp&w=3840&q=75)
![N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0039KY.webp&w=3840&q=75)
![1,2-Benzenediol, 4-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0002ZH.webp&w=3840&q=75)
![2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluoroph…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00ICN3.webp&w=3840&q=75)
